» Articles » PMID: 33505595

Effect of Metformin on Stem Cells: Molecular Mechanism and Clinical Prospect

Overview
Date 2021 Jan 28
PMID 33505595
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

Metformin is a first-line medication for type II diabetes. Numerous studies have shown that metformin not only has hypoglycemic effects, but also modulates many physiological and pathological processes ranging from aging and cancer to fracture healing. During these different physiological activities and pathological changes, stem cells usually play a core role. Thus, many studies have investigated the effects of metformin on stem cells. Metformin affects cell differentiation and has promising applications in stem cell medicine. It exerts anti-aging effects and can be applied to gerontology and regenerative medicine. The potential anti-cancer stem cell effect of metformin indicates that it can be an adjuvant therapy for cancers. Furthermore, metformin has beneficial effects against many other diseases including cardiovascular and autoimmune diseases. In this review, we summarize the effects of metformin on stem cells and provide an overview of its molecular mechanisms and clinical prospects.

Citing Articles

Moldable Alginate/Hydroxyapatite Hydrogel Loaded with Metformin Enhanced Regeneration of the Rabbit Mandibular Defects.

Nabavizadeh S, Shadi M, Khorraminejad-Shirazi M, Daneshi S, Tavanafar S, Naseri R J Maxillofac Oral Surg. 2024; 23(6):1391-1404.

PMID: 39618445 PMC: 11607265. DOI: 10.1007/s12663-023-02094-0.


Autophagy modulation effect on homotypic transfer of intracellular components via tunneling nanotubes in mesenchymal stem cells.

Sadeghsoltani F, Biray Avci C, Hassanpour P, Haiaty S, Rahmati M, Mota A Stem Cell Res Ther. 2024; 15(1):189.

PMID: 38956646 PMC: 11218273. DOI: 10.1186/s13287-024-03813-1.


Role of renin angiotensin system inhibitors and metformin in Glioblastoma Therapy: a review.

Dixon S, Oconnor A, Brooks-Noreiga C, Clark M, Levy A, Castejon A Cancer Chemother Pharmacol. 2024; 94(1):1-23.

PMID: 38914751 DOI: 10.1007/s00280-024-04686-0.


Drug repositioning in thyroid cancer treatment: the intriguing case of anti-diabetic drugs.

Greco A, Coperchini F, Croce L, Magri F, Teliti M, Rotondi M Front Pharmacol. 2023; 14:1303844.

PMID: 38146457 PMC: 10749369. DOI: 10.3389/fphar.2023.1303844.


Diabetes Mellitus and Gastric Cancer: Correlation and Potential Mechanisms.

Wang L, Zhang Z J Diabetes Res. 2023; 2023:4388437.

PMID: 38020199 PMC: 10653978. DOI: 10.1155/2023/4388437.


References
1.
Smieszek A, Tomaszewski K, Kornicka K, Marycz K . Metformin Promotes Osteogenic Differentiation of Adipose-Derived Stromal Cells and Exerts Pro-Osteogenic Effect Stimulating Bone Regeneration. J Clin Med. 2018; 7(12). PMC: 6306720. DOI: 10.3390/jcm7120482. View

2.
Smieszek A, Czyrek A, Basinska K, Trynda J, Skaradzinska A, Siudzinska A . Effect of Metformin on Viability, Morphology, and Ultrastructure of Mouse Bone Marrow-Derived Multipotent Mesenchymal Stromal Cells and Balb/3T3 Embryonic Fibroblast Cell Line. Biomed Res Int. 2015; 2015:769402. PMC: 4430655. DOI: 10.1155/2015/769402. View

3.
Fidaleo M, Cavallucci V, Pani G . Nutrients, neurogenesis and brain ageing: From disease mechanisms to therapeutic opportunities. Biochem Pharmacol. 2017; 141:63-76. DOI: 10.1016/j.bcp.2017.05.016. View

4.
Roohi A, Nikougoftar M, Montazeri H, Navabi S, Shokri F, Ostad S . High Glucose Affects the Cytotoxic Potential of Rapamycin, Metformin and Hydrogen Peroxide in Cultured Human Mesenchymal Stem Cells. Curr Mol Med. 2019; 19(9):688-698. DOI: 10.2174/1566524019666190722115842. View

5.
Bishnu A, Sakpal A, Ghosh N, Choudhury P, Chaudhury K, Ray P . Long term treatment of metformin impedes development of chemoresistance by regulating cancer stem cell differentiation through taurine generation in ovarian cancer cells. Int J Biochem Cell Biol. 2018; 107:116-127. DOI: 10.1016/j.biocel.2018.12.016. View